BioCentury
ARTICLE | Company News

Anergen autoimmune/inflammation, metabolic news

October 19, 1998 7:00 AM UTC

ANRG restructured its operations to conserve cash, reducing its headcount to 15-20 from about 50, and discontinuing all discovery research. The company said it will focus on the development of its Ane...